May 23, 2023 at a glance In a small study, a personalized mRNA vaccine against pancreatic cancer elicited a strong anti-tumor immune response in half of...
The efficacy and safety of atezolizumab as first-line therapy for advanced NSCLC with high levels of PD-L1 expression are unclear and require additional treatment options, the...
Recent Comments